Breath-hold 3D MR angiography of the renal vasculature using a contrast- enhanced multiecho gradient-echo technique

Investigative Radiology

Volumn 34, Issue 12, 1999, Pages 731-738

  Papachristopoulos, George ^a   Bis, Kostaki G ^a   Shetty, Anil N ^a   Ross, Michelle ^a   Bagga, Harp ^a   Shirkhoda, Ali ^a   Laub, Gerhard ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

MR angiography; Renal L; Three dimensional imaging

Indexed keywords

ADIPOSE TISSUE; ARTICLE; ARTIFACT; BREATH HOLDING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FIBROMUSCULAR DYSPLASIA; HUMAN; HUMAN TISSUE; KIDNEY BLOOD FLOW; KIDNEY PARENCHYMA; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; VASCULAR DISEASE;

EID: 0032746851     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199912000-00001     Document Type: Article

References (28)

1. Roobottom CA, Dubbins PA. Significant disease of the celiac and superior mesenteric arteries in asymptomatic patients: Predictive value of Doppler sonography. AJR 1993;161:985-988.
2. Carlos RC, Prince MR, Ward JS, et al. Renal anatomic changes on magnetic resonance imaging and gadolinium-enhanced magnetic resonance angiography after renal vascularization. Invest Radiol 1998;33:660-669.
3. Hany TF, Leung DA, Pfammatter T, Debatin JF. Contrast-enhanced magnetic resonance angiography of the renal arteries. Invest Radiol 1998;33:653-659.
4. Maki JH, Prince MR, Chenevert TC. Optimizing three-dimensional gadolinium-enhanced magnetic resonance angiography. Invest Radiol 1998;33:528-537.
5. Schoenberg SO, Knopp MV, Prince MR, at al. Arterial phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection. Invest Radiol 1998;33:506-514.
6. Loubeyre P, Trolliet P, Cahen R, et al. MR angiography of renal artery stenosis: value of the combination of three-dimensional time-of-flight and three-dimensional phase contrast MR angiography sequences. AJR 1996;167:489-494.
7. Strotzer M, Fellner CM, Geissler A, et al. Noninvasive assessment of renal artery stenosis. Acta Radiol 1995;36:243-247.
8. Gedroyc W. MRA of the renal arteries. Urol Clin North Am 1994;21: 201-214.
9. Snidow JJ, Johnson MS, Harris VJ, et al. Three-dimensional gadolinium enhanced MR angiography for aortoiliac inflow assessment plus renal artery screening in a single breath-hold. Radiology 1996; 198:725-732.
10. Hany TF, Debatin JF, Leung DA, Pfammatter T. Evaluation of the aortoiliac and renal arteries: Comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357-362.
11. Laub G, Kroeker R. Contrast-enhanced MR angiography with a multiecho gradient echo sequence [abstract]. Berkeley: International Society of Magnetic Resonance in Medicine, 1996:239.
12. Shirkhoda A, Konez O, Shetty AN, Bis KG, Ellwood RA, Kirsch MJ. Mesenteric circulation: Three-dimensional MR angiography with a gadolinium-enhanced multi-echo gradient-echo technique. Radiology 1997;202:257-261.
13. Shirkhoda A, Konez O, Shetty AN, Bis KG, Ellwood RA, Kirsch MJ. Contrast-enhanced MR angiography of the mesenteric circulation: A pictorial essay. Radiographies 1998;18:851-861.
14. Kopka I, Vosshenrich R, Rodenwalt J, Grabbe E. Differences in injection rates on contrast-enhanced breath-hold 3D MRA. Radiology 1998;170:345-348.
15. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191:155-164.
16. Creasy JL, Prince RR, Presbrey T, et al. Gadolinium-enhanced three-dimensional abdominal MR arteriography. J MRI 1993;3:877-881.
17. Mirowitz SA, Guterrez E, Lee JK, Brown JJ, Hieken JP. Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging. Radiology 1991;180:637-640.
18. Prince M, Arnoldus C, Frisoli J. Nephrotoxicity of high-dose gadolinium compared to iodinated contrast. J MRI 1996;6:162-166.
19. Runge VM, Parker JR. Worldwide clinical safety assessment of gadoteridol injection: an update. Eur Radiol 1997;7(Suppl 5):243-245.
20. Yoshikawa K, Davies A. Safety of Prohance in special populations. Eur Radiol 1997;7(Suppl 5):246-250.
21. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J MRI 1993;3:877-881.
22. Shetty AN, Shirkhoda A, Bis KG, Alcantara A. Contrast-enhanced 3D MR angiography in a single breath-hold: A novel technique. AJR 1995;165:1290-1293.
23. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995;196:371-378.
24. Prince MR, Narasimhan DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
25. Holland GA, Dougherty L, Carpenter JP, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. AJR 1996;166:971-981.
26. Boos M, Lentschig M, Scheffler K, Bongartz GM, Steinbrich W. Contrast-enhanced magnetic resonance angiography of peripheral vessels: Different contrast agent applications and sequence strategies: A review. Invest Radiol 1998;33:538-546.
27. Hany TF, Schmidt M, Hilfiker PR, Steiner P, Bachmann U, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced MRA of the pulmonary and renal arteries. Mag Reson Imaging 1998;16: 901-906.
28. Wilman AH, Riederer SJ. Performance of an elliptical centric view order for signal enhancement and motion artifact suppression in breath-hold three-dimensional gradient-echo imaging. Magn Reson Med 1997;38:793-802.